FIELD: chemistry.
SUBSTANCE: invention relates to a water-soluble non-agglomerative fullerene immunostimulating nanoparticle which consists of a hydrophobic fullerene core which is covalently bonded to a capronyl ligand through a piperazine spacer (1,2-dihydrofullerene-1-(6-piperazin-1-yl)-caproic acid) and a method for production thereof, which involves synthesis of pure 1,2- dihydrofullerene-1-(6-piperazin-1-yl)-caproic acid in four steps, the first of which involves obtaining 4-Boc-1-(5-ethoxycarbonyl-pentyl)-piperazine; the second step involves obtaining 6-(piperazin-1-yl)-caproic acid ethyl ether by dissolving 4-Boc-1-(5-ethoxycarbonyl-pentyl)-piperazine in 2N HCl and evaporating the obtained solution, pH of the precipitate of which is brought to a value of 10.0; extracting with ethyl acetate to dry the organic layer; the third step involves obtaining ethyl ether of 1,2- dihydrofullerene-1-(6-piperazin-1-yl)-caproic acid by mixing and stirring until dissolution of fullerene-C60 and toluene with addition, after dissolution, of Cp2TiCl2 and ethyl ether of 6-(piperazin-1-yl)-caproic acid and subsequent elution with a mixture of hexane and chloroform mixture, and the purified 1,2- dihydrofullerene-1-(6-piperazin-1-yl)-caproic acid in form of the finished product is obtained by dissolving ethyl ether of 1,2-dihydrofullerene-1-(6-piperazin-1-yl)-caproic acid in ethyl alcohol with addition of NaOH solution and heating the mixture while stirring until complete homogenisation. The pH of the reaction mixture is then brought to a neutral value and the precipitated acid is separated by microfiltration on filters for subsequent washing off of nanoparticle residue and evaporation of the drain residue, which consists of the water-soluble non-agglomerative fullerene immunostimulating nanoparticles, consisting of a hydrophobic fullerene core which is covalently bonded to a capronyl ligand through a piperazine spacer.
EFFECT: improved method.
4 cl, 4 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
INFLUENZA VACCINE | 2014 |
|
RU2546861C1 |
WATER-SOLUBLE AMINOFULLERENES AND METHODS OF OBTAINING THEM | 2005 |
|
RU2358904C2 |
NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES, METHOD FOR PREPARING THEM, COMPOSITIONS BASED ON NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES, USING NANOAGGREGATES OF WATER-SOLUBLE FULLERENE DERIVATIVES AND BASED COMPOSITIONS AS BIOLOGICALLY ACTIVE COMPOUNDS FOR REDUCING TOXICITY AND ENHANCING THERAPEUTIC ACTION OF DRUG PREPARATIONS, AND ALSO AS PREPARATIONS FOR TREATING ONCOLOGIC DISEASES | 2012 |
|
RU2550030C2 |
METHOD OF PRODUCING FULLERENE ADDUCTS | 2010 |
|
RU2462474C2 |
WATER-SOLUBLE NANOCOMPOSITES WITH FULLERENE C NANOPARTICLES IN POLY-N-VINYLPYRROLIDONE MATRIX AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2823484C1 |
METHOD OF OBTAINING PRODUCTS WITH ANTIBACTERIAL ACTIVITY FROM THE MYCELIUM OF BASIDIOMYCETES | 2022 |
|
RU2800356C1 |
METHOD FOR STIMULATING THE GROWTH OF MYCELIUM OF BASIDIOMYCETE FUNGI | 2022 |
|
RU2789886C1 |
METHOD FOR OBTAINING WATER-SOLUBLE COMPOUNDS OF FULLERENES AND GROWTH STIMULATORS BASED ON THEIR BASIS | 2020 |
|
RU2745971C1 |
USE OF WATER-SOLUBLE FULLERENE DERIVATIVES AS MEDICINAL PREPARATIONS OF NEUROPROTECTIVE AND ANTINEOPLASTIC ACTION | 2017 |
|
RU2704483C2 |
METHOD FOR PRODUCTION OF FULLERENE WATER-SALT DISPERSIONS | 2015 |
|
RU2630561C2 |
Authors
Dates
2014-04-20—Published
2012-12-04—Filed